CTKB
Cytek Biosciences Inc
5.40$
+0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.4% | 56.8% | 37.8% | 36.5% | 40.3% | 35.1% | 38.1% | 39.2% | 42.5% | 38.8% | 33.6% | 39.2% | 43.3% | 43.3% | 43.4% | 43.2% | 48.7% | 45.4% | 43.7% | 41.5% | 51.4% | 47.7% | 47.3% | 47.1% | 51.8% | 41.1% | 46.8% | |
| 46.6% | 43.2% | 62.2% | 63.5% | 59.7% | 64.9% | 61.9% | 60.8% | 57.5% | 61.2% | 66.4% | 60.8% | 56.7% | 56.7% | 56.6% | 56.8% | 51.3% | 54.6% | 56.3% | 58.5% | 48.6% | 52.3% | 52.7% | 52.9% | 48.2% | 58.9% | 53.2% | |
| 16.8% | 15.2% | 13.5% | 14.3% | 21.0% | 20.4% | 17.7% | 18.2% | 22.9% | 21.0% | 21.4% | 20.2% | 26.9% | 24.4% | 23.3% | 18.7% | 21.8% | 21.5% | 19.2% | 16.9% | 23.5% | 19.4% | 17.1% | 14.4% | 21.8% | 20.2% | 18.0% | |
| 14.1% | 13.1% | 6.7% | 8.6% | 16.4% | 13.7% | 16.7% | 17.8% | 21.5% | 21.4% | 19.9% | 21.8% | 32.6% | 21.7% | 21.6% | 18.5% | 25.4% | 25.1% | 21.2% | 15.8% | 31.1% | 29.7% | 30.8% | 26.4% | 41.8% | 35.0% | 32.8% | |
| 50.5% | 44.4% | 35.5% | 37.8% | 55.0% | 52.4% | 53.5% | 57.4% | 64.3% | 63.4% | 63.0% | 60.6% | 89.5% | 75.0% | 70.0% | 57.0% | 75.2% | 72.9% | 64.6% | 53.4% | 84.7% | 75.6% | 70.3% | 61.9% | 90.0% | 82.6% | 74.8% | |
| -3.9% | -1.1% | 26.7% | 25.7% | 4.7% | 12.5% | 8.4% | 3.4% | -6.7% | -2.2% | 3.4% | 0.2% | -32.8% | -18.4% | -13.4% | -0.2% | -23.9% | -18.3% | -8.2% | 5.2% | -36.1% | -23.3% | -17.6% | -9.0% | -41.8% | -23.7% | -21.6% | |
| 0.5% | 0.0% | 0.0% | 1.1% | 1.5% | 1.4% | 1.3% | 1.3% | 1.7% | 1.6% | 1.6% | 1.4% | 1.8% | 0.8% | 1.2% | 0.7% | 1.0% | 0.3% | 0.2% | 1.2% | 0.7% | 0.9% | 0.9% | 1.2% | 0.6% | 0.6% | 0.9% | |
| -3.7% | 1.0% | 27.5% | 26.1% | 0.6% | 10.7% | 6.0% | 1.1% | -9.4% | -3.5% | 4.6% | 8.5% | -24.4% | -13.3% | -8.7% | 7.1% | -20.0% | -15.4% | 0.3% | 18.0% | -27.2% | -14.9% | -14.9% | -6.5% | -39.4% | -24.2% | -19.7% | |
| 1.0% | -41.4% | 1.4% | 7.8% | 0.2% | 2.0% | 1.9% | 4.1% | -3.3% | -1.7% | 0.6% | 0.8% | -6.0% | -4.4% | 4.7% | -2.4% | -6.3% | 7.0% | -1.5% | 1.2% | 0.3% | -2.6% | -4.4% | 64.4% | 3.4% | 1.1% | 19.2% | |
| -4.7% | 42.4% | 26.1% | 18.3% | 0.4% | 8.8% | 4.1% | -3.1% | -5.8% | -1.5% | 4.1% | 7.3% | -18.4% | -8.8% | -13.5% | 9.4% | -13.8% | -22.4% | 1.8% | 16.8% | -27.5% | -12.2% | -10.5% | -70.9% | -42.7% | -25.3% | -39.0% | |
| -3.1% | 1.8% | 28.2% | 27.7% | 2.9% | 12.8% | 7.9% | 4.2% | -3.5% | 0.3% | 8.1% | 13.8% | -19.9% | -9.2% | -2.1% | 11.9% | -13.6% | -9.8% | 6.0% | -4.3% | -19.5% | -7.4% | -8.1% | -0.4% | -32.4% | -17.4% | -13.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.